[go: up one dir, main page]

CR9109A - Tratamiento de mastitis - Google Patents

Tratamiento de mastitis

Info

Publication number
CR9109A
CR9109A CR9109A CR9109A CR9109A CR 9109 A CR9109 A CR 9109A CR 9109 A CR9109 A CR 9109A CR 9109 A CR9109 A CR 9109A CR 9109 A CR9109 A CR 9109A
Authority
CR
Costa Rica
Prior art keywords
mastitis treatment
mastitis
treatment
enrofloxacin
ciprofloxacin
Prior art date
Application number
CR9109A
Other languages
English (en)
Inventor
Fraatz Krisitine
Froyman Robrecht
Pirro Franz
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35462240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9109(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of CR9109A publication Critical patent/CR9109A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

La invencion se refiere al tratamiento simplificado de mastitis con enrofloxacino o ciprofloxacino, particularmente en vacas.
CR9109A 2004-11-12 2007-05-09 Tratamiento de mastitis CR9109A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004054873A DE102004054873A1 (de) 2004-11-12 2004-11-12 Behandlung von Mastitis

Publications (1)

Publication Number Publication Date
CR9109A true CR9109A (es) 2007-10-04

Family

ID=35462240

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9109A CR9109A (es) 2004-11-12 2007-05-09 Tratamiento de mastitis

Country Status (27)

Country Link
US (2) US20070265275A1 (es)
EP (1) EP1812002B1 (es)
JP (2) JP2008519781A (es)
KR (1) KR20070084182A (es)
CN (1) CN101056638A (es)
AR (1) AR051763A1 (es)
AT (1) ATE526970T1 (es)
BR (1) BRPI0517473A (es)
CA (1) CA2587187A1 (es)
CR (1) CR9109A (es)
DE (2) DE102004054873A1 (es)
DK (1) DK1812002T3 (es)
ES (1) ES2373449T3 (es)
HR (1) HRP20120002T1 (es)
IL (1) IL182993A (es)
MX (1) MX2007005526A (es)
NO (1) NO20072890L (es)
NZ (1) NZ555062A (es)
PE (1) PE20061139A1 (es)
PL (1) PL1812002T3 (es)
PT (1) PT1812002E (es)
RU (1) RU2413514C2 (es)
SI (1) SI1812002T1 (es)
SV (1) SV2006002296A (es)
UA (1) UA92593C2 (es)
WO (1) WO2006050826A2 (es)
ZA (1) ZA200703695B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5217276B2 (ja) * 2007-07-19 2013-06-19 ニプロ株式会社 注射用抗菌剤の製造方法
GB2480276A (en) * 2010-05-11 2011-11-16 Michael Hilary Burke Process for the preparation of an aqueous injectable enrofloxacin antimicrobial formulation
CN101933927A (zh) * 2010-06-30 2011-01-05 洛阳惠中兽药有限公司 一种含恩诺沙星六水合物组合物及其在制备治疗或预防家畜疾病的药物中的应用
CN110522914A (zh) * 2012-06-29 2019-12-03 拜尔动物保健有限责任公司 药物组合物和乳腺炎的治疗
JP7000021B2 (ja) * 2013-03-15 2022-01-19 ジェンザイム・コーポレーション アミン官能性ポリアミド
RU2655772C1 (ru) * 2016-12-26 2018-05-29 Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" Йодсодержащий состав для лечения мастита у коров
RU2652354C1 (ru) * 2017-11-07 2018-04-25 федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный аграрный университет" (ФГБОУ ВО Волгоградский ГАУ) Способ терапии коров, больных маститом
CN108051512A (zh) * 2017-11-27 2018-05-18 佛山科学技术学院 一种牛乳中氟喹诺酮类药物残留量的检测方法
CN110812326B (zh) * 2019-11-04 2022-04-22 黑龙江省农业科学院畜牧兽医分院 一种辛伐他汀混悬乳剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3333719A1 (de) 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
DE3537761A1 (de) 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
DE19500784A1 (de) 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
CA2176298C (en) * 1995-06-27 2009-01-27 Dennis D. Copeland A single high dose fluoroquinolone treatment
GB0229642D0 (en) * 2002-12-20 2003-01-22 Pfizer Ltd Veterinary compositions for treating mastitis

Also Published As

Publication number Publication date
PE20061139A1 (es) 2006-12-29
EP1812002A2 (de) 2007-08-01
DE202005022066U1 (de) 2012-12-06
IL182993A0 (en) 2007-09-20
PL1812002T3 (pl) 2012-03-30
US20070265275A1 (en) 2007-11-15
ZA200703695B (en) 2008-08-27
UA92593C2 (ru) 2010-11-25
IL182993A (en) 2013-03-24
KR20070084182A (ko) 2007-08-24
HRP20120002T1 (hr) 2012-02-29
US20130023540A1 (en) 2013-01-24
NZ555062A (en) 2009-12-24
SI1812002T1 (sl) 2012-03-30
ES2373449T3 (es) 2012-02-03
ATE526970T1 (de) 2011-10-15
DK1812002T3 (da) 2012-02-06
WO2006050826A2 (de) 2006-05-18
CN101056638A (zh) 2007-10-17
NO20072890L (no) 2007-06-06
SV2006002296A (es) 2006-06-26
JP2008519781A (ja) 2008-06-12
PT1812002E (pt) 2011-12-30
CA2587187A1 (en) 2006-05-18
EP1812002B1 (de) 2011-10-05
WO2006050826A3 (de) 2006-07-27
DE102004054873A1 (de) 2006-05-18
RU2413514C2 (ru) 2011-03-10
JP2013063985A (ja) 2013-04-11
MX2007005526A (es) 2007-07-09
RU2007121516A (ru) 2008-12-20
BRPI0517473A (pt) 2008-10-07
AR051763A1 (es) 2007-02-07

Similar Documents

Publication Publication Date Title
CR9109A (es) Tratamiento de mastitis
EA200701918A1 (ru) Белок липокалин
CY1115713T1 (el) Παραγωγα ακρυλαμιδιου ως αντιβιοτικοι παραγοντες
UY3402Q (es) Diseno de tractor
ATE518010T1 (de) Aktive oberflächengekoppelte polymerasen
EA200702643A1 (ru) Антитела, связывающие tweak
EA201100908A1 (ru) Расширенные растворимые полипептиды рн20 и их использование
HN2008000311A (es) Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida
EA201101521A1 (ru) Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
MA32349B1 (fr) Antagonistes de la voie hedgehog a base de phtalazines disubstituees
HN2011000876A (es) Inhibidores de las enzimas de proteina cinaza activadas por mitogeno p38
HN2008000189A (es) Concentrados de proteina de maiz
EA201000903A1 (ru) Антитела к pcrv-антигену pseudomonas aeruginosa
NO20083245L (no) Sykliske antimikrobielle peptider
EA200870019A1 (ru) Лактамовые соединения и способы их применения
MX2009012767A (es) Metodos de tratamiento de infecciones fungicas.
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
FR2917944B1 (fr) Pretailleuse de cultures palissees, en particulier de la vigne.
WO2007047608A3 (en) Fibrin targeted therapeutics
ATE510822T1 (de) Kaliumkanalinhibitoren
DE602005015963D1 (de) Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
BRPI0413982A (pt) derivados de alfa-aminoamida úteis como agentes anti-inflamatórios
EA200800342A1 (ru) ИНГИБИТОРЫ Glepp-1 ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И/ИЛИ ВОСПАЛИТЕЛЬНЫХ РАССТРОЙСТВ